Search

中文 / English

Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
 Copyright: Beijing Minhai Biological Technology Co., Ltd.    京ICP备10007676号-1   Powered by  www.300.cn Beijing    Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173           

Contact

Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Recruitment: 010-59613547
Marketing: 010-59613639
Medical support: 010-57864983

                             010-59613669

400 :4001899806

Links:

>
>
>
Vaccine, fight or not? The voices uploaded by these two sessions are dry goods

Vaccine, fight or not? The voices uploaded by these two sessions are dry goods

Release time:
2019/03/11
Page view
Vaccine management legislation will be promoted!
 
On the morning of March 4, the second session of the 13th National People's Congress held a press conference in the press hall of the Great Hall of the People. The spokesperson of the conference, Zhang Yesui, clearly stated that 2019 will focus on four aspects of legislative work, including the review of the vaccine management law draft.
 
Editor's Interpretation: This means that China will make specific advances in vaccine management legislation this year. Under the framework of governing the country according to law, it is certainly a good thing for vaccine management!

△图/大会发言人张业遂

 

Vaccine, fight or not?
 
At a press conference held by the National Health Commission on February 25, Gao Fu, member of the National Committee of the Chinese People's Political Consultative Conference, member of the Chinese Academy of Sciences, and director of the Chinese Center for Disease Control and Prevention, said in response to questions from reporters, whether from China or internationally, vaccination Vaccines are an effective way to prevent and control diseases.
 
 
 
Survey data of the Chinese Center for Disease Control shows that the current vaccination rate of the national immunization program is over 90%. In the past, smallpox was successfully eliminated through vaccination; through the vaccination of hepatitis B, the incidence of hepatitis B in children under 5 years of age was successfully controlled at 0.3 %the following.
 
 
Editor's Interpretation: The vaccine should be delivered. Don't listen to the words "It's safer not to vaccinate your child"!
 
 
 
Figure / National Health and Health Commission held a press conference, inviting representatives of the National People's Congress and the National People's Congress in the medical and health field to discuss the hotspots of the two sessions this year.
 
 
Can domestic vaccines still be given?
 
 
Or at a press conference held by the National Health Commission on February 25, Gao Fu said: In the past year, relevant departments have set up a immunization planning working group to analyze the vaccine incidents in recent years.
 
 
"If the vaccine quality problem is solved by the quality supervision department, if it is a problem in the circulation management link, then we will assist these departments to solve it." The key to properly controlling the vaccine is two points. One is to improve the level of scientific research. The second is joint management. In the future, we will focus on the above two points and provide the public with safe, effective, and quality-controllable vaccines.
 
 
Gao Fu pointed out: From the perspective of quality, China's vaccine is one of the best vaccines in the world. Don't lose confidence in the vaccine's immunization effect, let alone lose confidence in China's vaccine.
 
 
What are the feasible measures to ensure the safety of vaccines?
 
 
 
Data Map: Fang Laiying, member of the National Committee of the Chinese People's Political Consultative Conference
 
At the two sessions, many of the proposals and proposals of the deputies and committees made suggestions on vaccine safety. Fang Laiying, member of the National Committee of the Chinese People's Political Consultative Conference and vice president of the Chinese Hospital Association, suggested that a vaccine management traceability system be established.
 
I suggest establishing a drug traceability system to ensure the quality and safety of drugs and vaccines. In the event of a drug safety incident, it can be quickly recalled and even accurately "located" to a certain patient.
 
There are two keywords, "one box and one code" and "one code to the end". Specifically, it is necessary to be able to "one code to the end" from the manufacturing process of the product to the circulation and use, and to achieve "one box and one code", which means that each small box is marked with a code for accurate identification. According to our modern technology, it can be done one box and one yard. However, it is problematic to use one batch of one barcode, for example, a certain genuine medicine is "25078 batch", but the fake medicine can also be pretended to be "25078 batch".
 
On the one hand, the flow of drugs can be accurately located, and consumers who can find the end can know who bought the box of drugs. In case of problems, they can be recalled promptly and accurately.
 
On the other hand, big data for medicines can be formed, which is especially helpful for drug counterfeiting. For example, there are 50,000 boxes of medicines in a batch, and as a result, there are 60,000 boxes found on the market, which must be 10,000 boxes. We can use the drug traceability system to accurately locate fake medicines. benefit.
 
In addition, the establishment of a traceability system will definitely use modern information technology, which will also be beneficial to promoting the construction of the Internet of Medicines. For example, the current hospitals are developing intelligently and electronically. The construction of the drug traceability system can lay the foundation and conditions for the future construction of the Internet of Things, thereby effectively reducing the cost of social management. We have the ability to do this.